Parallel community solutions for cardiovascular risk reduction

Affiliations

¹ Program in Health Services & Systems Research, Duke NUS Medical School, 169857, Singapore; Department of Medicine, Aga Khan University, Karachi, Pakistan; Duke Global Health Institute, Duke University, Durham, NC USA. Electronic address: tazeen.jafar@duke-nus.edu.sg.
² Department of Medicine, Aga Khan University, Karachi, Pakistan; Division of Cardiology, Duke University, Durham, NC, USA.
³ Division of Cardiology, Duke University, Durham, NC, USA; Duke Global Health Institute, Duke University, Durham, NC USA.

Comment

Tazeen H Jafar et al. Lancet. 2019.

. 2019 Oct 5;394(10205):1207-1208.

doi: 10.1016/S0140-6736(19)31995-6. Epub 2019 Sep 2.

¹ Program in Health Services & Systems Research, Duke NUS Medical School, 169857, Singapore; Department of Medicine, Aga Khan University, Karachi, Pakistan; Duke Global Health Institute, Duke University, Durham, NC USA. Electronic address: tazeen.jafar@duke-nus.edu.sg.
² Department of Medicine, Aga Khan University, Karachi, Pakistan; Division of Cardiology, Duke University, Durham, NC, USA.
³ Division of Cardiology, Duke University, Durham, NC, USA; Duke Global Health Institute, Duke University, Durham, NC USA.

No abstract available

Comment on

A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.
Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S. Schwalm JD, et al. Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2. Lancet. 2019. PMID: 31488369 Clinical Trial.